Oncotect is a Raleigh-based biotech startup committed to pioneering early screening of cancer risks in dogs using their urine.
Oncotect has raised $200K in total funding. The most recent round was Pre-Seed. The last funding was announced in February 2023.
Oncotect's investors include Leap Venture Studio, North Carolina Biotechnology Center, Michelson Impact Ventures, NC IDEA MICRO.
Oncotect is headquartered in Raleigh, United States.
Oncotect is a Raleigh-based biotech startup committed to pioneering early screening of cancer risks in dogs using their urine.
Oncotect is at the Pre-Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Oncotect — Funding & Investors." VCBacked, February 27, 2023, https://www.vcbacked.co/company/oncotect. Accessed September 30, 2026.
VCBacked. (2023). Oncotect — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/oncotect
{{cite web |title=Oncotect — Funding & Investors |url=https://www.vcbacked.co/company/oncotect |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated